CM Life Sciences (CMLF) to Combine with Sema4 in $2.1Bn Deal

sema4-logo

CM Life Sciences (CMLF) to Combine with Sema4 in $2.1Bn Deal

CM Life Sciences (CMLF) announced this morning that it had entered into a definitive business combination agreement with Sema4, an AI and machine learning-driven patient-centered genomic and clinical data intelligence company. Founded in 2016, Sema4 is dedicated to transforming healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.